Pangaea Oncology Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.98	3.34	1.38	7.1	2.02
Short-Term Investments	1.1	1.1	1.41	1.41	0.91
Cash & Short-Term Investments	3.07	4.43	2.79	8.51	2.93
Cash Growth	-30.66%	58.86%	-67.22%	190.44%	180.59%
Accounts Receivable	6.92	7.26	5.79	3.66	3.6
Other Receivables	0.52	0.58	0.59	0.67	0.48
Total Trade Receivables	7.44	7.84	6.38	4.33	4.07
Inventory	0.72	0.7	0.54	0.41	0.51
Other Current Assets	2.74	1.24	1.45	1.47	0.92
Total Current Assets	12.87	13.12	9.75	13.31	7.52
Net Property, Plant & Equipment	1.22	0.9	0.55	0.35	0.43
Other Intangible Assets	12.82	12.97	12.69	9.64	8.23
Goodwill	2.14	2.42	2.7	0.55	0.05
Long-Term Investments	0.08	0.11	0.06	0.55	0.62
Other Long-Term Assets	2.97	2.89	2.69	3.98	4.01
Total Assets	32.11	32.41	28.43	28.38	20.85
Accounts Payable	2.65	2.23	2.33	0.86	0.74
Accrued Expenses	0.87	0.81	0.92	0.34	0.3
Short-Term Debt	3.61	3.84	3.53	1.47	2.09
Current Portion of Leases	0.02	0.02	-	-	-
Unearned Revenue	0.08	0.09	0.06	0.05	0.05
Other Current Liabilities	0.02	0.02	0.02	0.01	0.01
Total Current Liabilities	7.25	7.01	6.86	2.72	3.18
Long-Term Debt	2.17	1.71	1.86	2.28	3.27
Long-Term Leases	0.02	0.04	-	-	-
Other Long-Term Liabilities	0.6	0.81	0.99	0.29	0.31
Total Long-Term Liabilities	2.8	2.56	2.85	2.58	3.58
Total Liabilities	10.05	9.57	9.71	5.3	6.76
Common Stock	0.72	0.69	0.61	0.61	0.45
Treasury Stock	-0.48	-0.47	-0.45	-0.07	-0.09
Additional Paid-in Capital	37.69	34.79	29.01	29.51	17.31
Accumulated Other Comprehensive Income	0.48	0.6	0.71	0.75	0.81
Retained Earnings	-20.65	-14.66	-16.4	-7.88	-5.04
Total Common Shareholders' Equity	20.81	21.5	17.27	22.15	13.28
Minority Interest	0.76	0.73	0.74	0.18	-
Shareholders' Equity	22.06	22.84	18.71	23.08	14.09
Total Liabilities & Equity	32.11	32.41	28.43	28.38	20.85
Total Debt	5.82	5.61	5.39	3.75	5.36
Net Cash (Debt)	-2.75	-1.18	-2.6	4.76	-2.42
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.08	-0.03	-0.09	0.16	-0.11
Book Value	20.81	21.5	17.27	22.15	13.28
Book Value Per Share	0.58	0.63	0.57	0.73	0.59
Tangible Book Value	5.85	6.12	1.89	11.96	5
Tangible Book Value Per Share	0.16	0.18	0.06	0.39	0.22